These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2076575)

  • 1. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan.
    Nishioka Y; Kyotani S; Masui H; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3074-7. PubMed ID: 2632057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs, and changes of cisplatin content in blood and tissue.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Sakamoto Y; Morita M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):267-8. PubMed ID: 1576685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
    Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
    Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the formulation design of chitosan microspheres containing cisplatin.
    Wang YM; Sato H; Adachi I; Horikoshi I
    J Pharm Sci; 1996 Nov; 85(11):1204-10. PubMed ID: 8923326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: antitumor effect of cis-diamminedichloroplatinum(II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors.
    Kyotani S; Nishioka Y; Okamura M; Tanaka T; Miyazaki M; Ohnishi S; Yamamoto Y; Ito K; Ogiso T; Tanada S
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2814-6. PubMed ID: 1464114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation variables on cis-platin loaded chitosan microsphere properties.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1999; 16(6):697-703. PubMed ID: 10575622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
    Machida Y; Nagai T; Abe M; Sannan T
    Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: effects of particle size and dose on chitin-containing cis-diamminedichloroplatinum(II) albumin microsphere antitumor activity in VX2 hepatic tumor model rabbits.
    Nishioka Y; Kyotani S; Okamura M; Ohnishi S; Yamamoto Y; Kawashima Y; Tanada S; Nakamura T
    Biol Pharm Bull; 1994 Sep; 17(9):1251-5. PubMed ID: 7841948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The development of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma].
    Kyotani S; Nishioka Y
    Yakugaku Zasshi; 2000 Nov; 120(11):1173-84. PubMed ID: 11190202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
    Thanoo BC; Sunny MC; Jayakrishnan A
    J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs].
    Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
    Yao Xue Xue Bao; 1995 Dec; 30(12):891-5. PubMed ID: 8712014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: effects of chitin concentration on cis-diamminedichloroplatinum(II) albumin microsphere properties and antitumor effect in VX2 hepatocellular carcinoma model rabbits.
    Nishioka Y; Kyotani S; Okamura M; Ohnishi S; Yamamoto Y; Tanada S; Nakamura T
    Biol Pharm Bull; 1993 Nov; 16(11):1136-9. PubMed ID: 8312871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
    Bayomi MA
    Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
    Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods.
    Mi FL; Wong TB; Shyu SS
    J Microencapsul; 1997; 14(5):577-91. PubMed ID: 9292434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.